Compare Wockhardt with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs STERLING BIOTECH - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT STERLING BIOTECH WOCKHARDT/
STERLING BIOTECH
 
P/E (TTM) x -20.9 -0.4 - View Chart
P/BV x 1.1 0.0 7,734.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 WOCKHARDT   STERLING BIOTECH
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
STERLING BIOTECH
Dec-13
WOCKHARDT/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,01211 9,638.1%   
Low Rs5323 15,632.4%   
Sales per share (Unadj.) Rs355.926.8 1,327.5%  
Earnings per share (Unadj.) Rs-60.3-15.0 403.0%  
Cash flow per share (Unadj.) Rs-46.8-5.5 856.0%  
Dividends per share (Unadj.) Rs0.010-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs257.854.9 469.8%  
Shares outstanding (eoy) m110.63267.87 41.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.20.3 836.5%   
Avg P/E ratio x-12.8-0.5 2,755.4%  
P/CF ratio (eoy) x-16.5-1.3 1,297.2%  
Price / Book Value ratio x3.00.1 2,363.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m85,3791,862 4,586.1%   
No. of employees `0006.31.4 461.9%   
Total wages/salary Rs m9,371547 1,713.7%   
Avg. sales/employee Rs Th6,295.05,303.3 118.7%   
Avg. wages/employee Rs Th1,498.3403.8 371.0%   
Avg. net profit/employee Rs Th-1,066.3-2,959.0 36.0%   
INCOME DATA
Net Sales Rs m39,3697,181 548.3%  
Other income Rs m1,20243 2,822.3%   
Total revenues Rs m40,5717,223 561.7%   
Gross profit Rs m18947 1.9%  
Depreciation Rs m1,4952,543 58.8%   
Interest Rs m2,5554,377 58.4%   
Profit before tax Rs m-2,830-5,931 47.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m257-1,924 -13.4%   
Profit after tax Rs m-6,669-4,007 166.4%  
Gross profit margin %013.2 0.4%  
Effective tax rate %-9.132.4 -28.0%   
Net profit margin %-16.9-55.8 30.4%  
BALANCE SHEET DATA
Current assets Rs m33,79614,335 235.8%   
Current liabilities Rs m26,91749,809 54.0%   
Net working cap to sales %17.5-494.0 -3.5%  
Current ratio x1.30.3 436.3%  
Inventory Days Days79403 19.7%  
Debtors Days Days89171 52.3%  
Net fixed assets Rs m39,66455,432 71.6%   
Share capital Rs m553268 206.5%   
"Free" reserves Rs m27,96813,935 200.7%   
Net worth Rs m28,52214,701 194.0%   
Long term debt Rs m21,7319,478 229.3%   
Total assets Rs m81,62073,988 110.3%  
Interest coverage x-0.1-0.4 30.3%   
Debt to equity ratio x0.80.6 118.2%  
Sales to assets ratio x0.50.1 497.0%   
Return on assets %-5.00.5 -1,006.2%  
Return on equity %-23.4-27.3 85.8%  
Return on capital %-7.7-6.4 119.4%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m9,8071,860 527.3%   
Fx outflow Rs m1,78925 7,186.0%   
Net fx Rs m8,0191,835 437.0%   
CASH FLOW
From Operations Rs m6841,719 39.8%  
From Investments Rs m6,302-3,148 -200.2%  
From Financial Activity Rs m-7,6951,426 -539.6%  
Net Cashflow Rs m-664-3 19,529.4%  

Share Holding

Indian Promoters % 74.5 33.9 219.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 0.0 -  
FIIs % 7.7 9.9 77.8%  
ADR/GDR % 0.1 16.9 0.6%  
Free float % 15.4 39.3 39.2%  
Shareholders   67,757 21,482 315.4%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   IPCA LABS  SANOFI INDIA  ALEMBIC PHARMA  ORCHID PHARMA LTD  NOVARTIS  

Compare WOCKHARDT With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Flat; L&T and Tech Mahindra Top Losers(12:30 pm)

Share markets in India are presently trading on a volatile note. Sectoral indices are trading mixed with stocks in the capital goods sector and realty sector.

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (2QFY19); Net Profit Down 158.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, WOCKHARDT LTD. has posted a net profit of Rs 228 m (down 158.2% YoY). Sales on the other hand came in at Rs 11 bn (up 10.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (1QFY19); Net Profit Down 81.4% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, WOCKHARDT LTD. has posted a net profit of Rs 862 m (down 81.4% YoY). Sales on the other hand came in at Rs 10 bn (up 13.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Nov 13, 2019 12:25 PM

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT - ORCHID PHARMA LTD COMPARISON

COMPARE WOCKHARDT WITH

MARKET STATS